Bg pattern

METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PROSPECTUS: INFORMATION FOR THE USER

Metoclopramide Pensa 1 mg/ml oral solution EFG

Read the entire prospectus carefully before starting to take this medication, as it contains important information for you.

  • Keep this prospectus, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects that do not appear in this prospectus. See section 4.

Contents of the prospectus:

  1. What Metoclopramide Pensa is and what it is used for
  2. What you need to know before taking Metoclopramide Pensa
  3. How to take Metoclopramide Pensa
  4. Possible side effects
  5. Storage of Metoclopramide Pensa
  6. Package contents and additional information

1. What Metoclopramide Pensa is and what it is used for

Metoclopramide Pensa is an antiemetic. It contains a medication called "metoclopramide". It acts on an area of the brain that prevents nausea or vomiting.

Adult population

Metoclopramide Pensa is used in adults:

  • to prevent delayed nausea and vomiting that may appear after chemotherapy
  • to prevent nausea and vomiting caused by radiotherapy
  • to treat nausea and vomiting, including nausea and vomiting that may appear with migraine.

Metoclopramide can be taken in combination with oral analgesics in the case of migraine so that the analgesics are more effective.

Pediatric population

Metoclopramide Pensa is indicated in children (1-18 years) if other treatments do not work or cannot be used to prevent delayed nausea and vomiting that may appear after chemotherapy.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Metoclopramide Pensa

Do not take Metoclopramide Pensa

  • if you are allergic to metoclopramide or any of the other components of this medication (listed in section 6).
  • if you have bleeding, obstruction, or perforation in the stomach or intestine.
  • if you have or may have a rare adrenal gland tumor, which is near the kidney (pheochromocytoma).
  • if you have ever had involuntary muscle spasms (tardive dyskinesia) when treated with this medication.
  • if you have epilepsy
  • if you have Parkinson's disease
  • if you are taking levodopa (medication for Parkinson's disease) or dopaminergic agonists (see below "Use of Metoclopramide Pensa with other medications").
  • if you have ever had abnormal blood pigment levels (methemoglobinemia) or NADH cytochrome b5 reductase deficiency.

Do not administer Metoclopramide Pensa to children under 1 year of age (see below "Children and adolescents").

Do not take Metoclopramide Pensa if any of the above cases apply to you. If you are unsure, consult your doctor, pharmacist, or nurse before taking Metoclopramide Pensa.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before taking Metoclopramide Pensa if:

  • you have a history of abnormal heartbeats (prolonged QT interval) or any other heart problem.
  • you have problems with salt levels in your blood, such as potassium, sodium, and magnesium.
  • you are using other medications known to affect the way your heart beats
  • you have any neurological problem (brain)
  • you have liver or kidney problems. The dose may need to be reduced (see section 3).

Your doctor may perform blood tests to monitor your blood pigment levels. In cases of abnormal levels (methemoglobinemia), treatment should be discontinued immediately and permanently.

You should wait at least 6 hours between each dose of metoclopramide, even in the case of vomiting or rejection of the dose, to avoid overdose.

Do not exceed 3 months of treatment due to the risk of involuntary muscle spasms.

Consult your doctor or pharmacist if such symptoms appear.

Children and adolescents

Uncontrollable movements (extrapyramidal disorders) may appear in children and young adults. This medication should not be used in children under 1 year of age due to the high risk of uncontrollable movements (see above "Do not take Metoclopramide Pensa")

Use of Metoclopramide Pensa with other medications

Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or may need to take any other medication. This is because some medications can affect the way Metoclopramide Pensa works or Metoclopramide Pensa may affect the way other medications work. These medications include:

  • levodopa or other medications used to treat Parkinson's disease (see above "Do not take Metoclopramide Pensa")
  • anticholinergics (medications used to relieve stomach spasms or cramps)
  • opioid derivatives (medications used to treat intense pain)
  • sedatives
  • any medication used to treat mental health problems
  • digoxin (medication used to treat heart failure)
  • cyclosporine (medication used to treat some immune system problems)
  • mivacurium and suxamethonium (medications used to relax muscles)
  • fluoxetine and paroxetine (medications for treating depression)

Use of Metoclopramide Pensa with alcohol

Do not consume alcohol during treatment with metoclopramide because it increases the sedative effect of Metoclopramide Pensa.

Pregnancy and breastfeeding

Pregnancy

If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

If necessary, Metoclopramide Pensa can be taken during pregnancy. Your doctor will decide whether or not to administer this medication.

Breastfeeding

Metoclopramide Pensa is not recommended if you are breastfeeding because metoclopramide passes into breast milk and may affect your baby.

Driving and using machines

After taking Metoclopramide Pensa, you may feel drowsy, dizzy, or have uncontrollable movements, tics, or muscle spasms that can affect your vision and interfere with your ability to drive and use machines.

Important information about some of the components of this medication

It may cause allergic reactions (possibly delayed) because it contains propyl parahydroxybenzoate (E-216) and methyl parahydroxybenzoate (E-218).

3. How to take Metoclopramide Pensa

Follow the administration instructions of Metoclopramide Pensa indicated by your doctor. Consult your doctor or pharmacist if you have doubts.

Dosage

  • All indications (adult patients):a single dose of 10 mg (10 ml) is recommended, which can be repeated up to three times a day.

The maximum daily recommended dose is 30 mg (30 ml) or 0.5 mg/kg of body weight.

The maximum treatment duration is 5 days.

  • To prevent delayed nausea and vomiting that may appear after chemotherapy (children 1-18 years old)

The recommended dose is 0.1 to 0.15 mg/kg of body weight, which can be repeated up to three times a day, taken orally.

The maximum dose in 24 hours is 0.5 mg/kg of body weight

Dosing table

Age

Body weight

Dose

Frequency

1-3 years

10-14 kg

1 mg

Up to 3 times a day

3-5 years

15-19 kg

2 mg

Up to 3 times a day

5-9 years

20-29 kg

2.5 mg

Up to 3 times a day

9-18 years

30-60 kg

5 mg

Up to 3 times a day

15-18 years

Over 60 kg

10 mg

Up to 3 times a day

Use the dosing cap included in the package of the oral solution to administer the correct dose of metoclopramide.

The dosing cap is graduated in ml. The correspondence with body weight is detailed in the dosing table.

Do not take this medication for more than 5 days to prevent delayed nausea and vomiting that may appear after chemotherapy.

Method of administration

Metoclopramide Pensa is administered orally.

You should wait at least 6 hours between each dose of metoclopramide, even in the case of vomiting or rejection of the dose, to avoid overdose.

Elderly population

The dose may need to be reduced depending on kidney problems, liver problems, and general health problems.

Adults with kidney problems

Inform your doctor if you have kidney problems. The dose should be reduced if you have moderate to severe kidney problems.

Adults with liver problems

Inform your doctor if you have liver problems. The dose should be reduced if you have severe liver problems.

Children and adolescents

Metoclopramide should not be used in children under 1 year of age (see section 2).

If you take more Metoclopramide Pensa than you should

Contact your doctor or pharmacist immediately. You may experience uncontrollable movements (extrapyramidal disorders), feel drowsy, have some problems with consciousness, be confused, have hallucinations, and heart problems. Your doctor may prescribe a treatment for these effects if necessary.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, tel. 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take Metoclopramide Pensa

Do not take a double dose to make up for forgotten doses.

If you have any doubts about the use of this medication, ask your doctor, nurse, or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not all people experience them.

Stop treatment and inform your doctor, pharmacist, or nurse immediately if you experience one of the following signs while taking this medication:

  • uncontrollable movements (which often affect the head and neck). These can appear in children and young adults, particularly when high doses are used. These signs usually appear at the beginning of treatment and can even occur after a single administration. These movements will stop when treated properly.
  • high fever, high blood pressure, convulsions, sweating, saliva production. These can be signs of a condition called malignant neuroleptic syndrome.
  • itching and skin rash, facial swelling, lips or throat, difficulty breathing. These can be signs of an allergic reaction, which can be severe.

Very common (may affect more than 1 in 10 people)

  • feeling drowsy

Common (may affect up to 1 in 10 people):

  • depression
  • uncontrollable movements such as tics, twitches, torsion movements, or muscle contractions (stiffness, rigidity)
  • symptoms similar to Parkinson's disease (stiffness, tremors)
  • feeling restless
  • decreased blood pressure (particularly with intravenous administration)
  • diarrhea
  • feeling weak

Uncommon (may affect up to 1 in 100 people)

  • high levels of a hormone called prolactin in the blood, which can cause: milk production in men and women who are not breastfeeding.
  • irregular periods
  • hallucinations
  • decreased level of consciousness
  • slow heart rate (particularly with intravenous administration)
  • allergy
  • visual disturbances and involuntary deviation of the eyeball

Rare (may affect up to 1 in 1,000 people):

  • confusion
  • convulsions (especially in patients with epilepsy).

Frequency not known (frequency cannot be estimated from available data)

  • abnormal blood pigment levels: which can change the color of your skin
  • abnormal development of the breasts (gynecomastia)
  • involuntary muscle spasms after prolonged use, particularly in elderly patients
  • high fever, high blood pressure, convulsions, sweating, saliva production. These can be signs of a condition called malignant neuroleptic syndrome
  • changes in heartbeats, which can be seen on an ECG (electrocardiogram)
  • cardiac arrest (particularly with intravenous administration)
  • shock (sharp drop in blood pressure) (particularly with intravenous administration)
  • fainting (particularly with intravenous administration)
  • allergic reaction that can be severe (particularly with intravenous administration)
  • very high blood pressure

Reporting side effects:

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Metoclopramide Pensa

Keep this medication out of sight and reach of children.

No special storage conditions are required.

Do not use Metoclopramide Pensa after the expiration date that appears on the packaging and on the bottle after CAD. The expiration date is the last day of the month indicated.

Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Metoclopramide Pensa 1 mg/ml oral solution

  • The active ingredient is metoclopramide. Each ml of solution contains 1 mg of metoclopramide hydrochloride.
  • The other components are: hydroxyethylcellulose, sodium saccharin, methyl parahydroxybenzoate (E-218), propyl parahydroxybenzoate (E-216), citric acid monohydrate, lemon essence, lime flavor, purified water.

Appearance of the product and package contents

Metoclopramide Pensa 1 mg/ml oral solution is a solution packaged in a topaz-colored plastic bottle with 250 ml of solution and a 10 ml dosing cap for oral administration.

Marketing authorization holder

Towa Pharmaceutical, S.A.

C/ de Sant Martí, 75-97

08107 Martorelles (Barcelona)

Spain

Manufacturer

Kern Pharma, S.L.

Polígono Ind. Colón II. c/Venus, 72

08228 Terrassa (Barcelona)

Spain

This prospectus was approved in September 2019

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION

Discuss questions about METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION?
METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION?
The active ingredient in METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION is metoclopramide. This information helps identify medicines with the same composition but different brand names.
How much does METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION cost in pharmacies?
The average pharmacy price for METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION is around 2.5 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION?
METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION is manufactured by Towa Pharmaceutical S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to METOCLOPRAMIDE PENSA 1 mg/ml ORAL SOLUTION?
Other medicines with the same active substance (metoclopramide) include METOCLOPRAMIDE ACCORD 10 mg TABLETS, METOCLOPRAMIDE BASE 5 mg/mL Injectable Solution and Infusion Solution, METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media